Humacyte, a Durham-based regenerative medicine company, has begun another clinical trial of Humacyl, its bioengineered blood vessel, this time in patients with vascular trauma.
Read More
Six North Carolina bioscience companies are among 15 companies from the Southeast selected as finalists for awards to be given at the 20th annual SEBIO Investor and Partnering Forum in Atlanta next month.
Read More
In our latest roundup of tech and life science news from North Carolina companies, check out updates from SAS, LendingTree, SunTech Medical, Humacyte and RumbleOn.
Read More
The trickle-down effect of a “frothy” life science venture funding and exit market is having a trickle-down effect on the Triangle startup ecosystem. But is that necessarily a good thing?
Read MoreAfter raising $250 million in equity since March, Humacyte has named Jeffrey Lawson president and CEO.
Read More
